Adaptimmune Therapeutics 2020 Annual Report 10-K

Adaptimmune Therapeutics PLC's Form 10-K annual report for fiscal year 2020, detailing the immunotherapy company's financial performance, business operations, risk factors, and strategic initiatives. The UK-based biotech firm develops cell therapy treatments including its proprietary SPEAR platform.